Search For "bharat biotech"
Bharat Biotech's Covaxin gets emergency use approval from DCGI for kids ab
Updated : 4 years, 3 months ago IST
New Delhi [India], December 25 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI) for emergency use for kids aged between 12-18 years, official sources said.
Read More
Bharat Biotech seeks DCGI's approval for its intranasal COVID-19 booster d
Updated : 4 years, 3 months ago IST
New Delhi [India], December 20 (ANI): As India is witnessing a surge in cases of "highly transmissible" Omicron variant, Hyderabad-based Bharat Biotech has submitted the phase 3 clinical trial application to the Drugs Controller General of India (DCGI) to get approval for the booster dose
Read More
Bharat Biotech Chairman meets Vietnam Dy Health Min, discusses Covaxin COV
Updated : 4 years, 3 months ago IST
New Delhi [India], December 18 (ANI): Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech along with Suchitra Ella Joint Managing Director, Bharat Biotech, met Professor, Dr Tran Van Thuan, Deputy Minister of Health, Government of the Socialist Republic of Vietnam, in New Delh
Read More
Bharat Biotech donates 2 lakh Covaxin doses to Vietnam
Updated : 4 years, 3 months ago IST
New Delhi [India], December 16 (ANI): Hyderabad-based biotechnology company Bharat Biotech on Thursday announced that it will donate two lakh doses of its COVID-19 vaccine Covaxin to Vietnam.
Read More
COVID-19 vaccination for children: CDSCO approved ZyCoV-D for restricted u
Updated : 4 years, 3 months ago IST
New Delhi [India], November 30 (ANI): The Interim Phase II, III clinical trial data of COVAXIN on Healthy Volunteers aged 2 to 18 years submitted by Bharat Biotech was deliberated in the meeting of the Subject Expert Committee (SEC) on August 28 and October 11, informed Ministry of Health an
Read More
Lancet Infectious Diseases study compare well with phase 3 clinical trials
Updated : 4 years, 4 months ago IST
New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obt
Read More
Covaxin true success story of public-private partnership, says Bharat Biot
Updated : 4 years, 4 months ago IST
New Delhi [India], November 24 (ANI): The development of the country's indigenous COVID-19 vaccine Covaxin is a true success story for public-private partnerships in India, which is based on mutual respect, trust and transparency, said Dr Krishna Ella, Chairman and Managing Director, Bharat
Read More
COVID-19: Bahrain approves Bharat Biotech's Covaxin
Updated : 4 years, 4 months ago IST
Manama [Bahrain], November 12 (ANI): Bahrain has approved the emergency use of India's indigenously developed COVID-19 vaccination--Covaxin.
Read More
Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy against COVID
Updated : 4 years, 4 months ago IST
Hyderabad (Telangana) [India], November 12 (ANI): Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech's Covaxin.
Read More
Booster dose of COVID-19 vaccine required if virus gets mutated, says Bhar
Updated : 4 years, 4 months ago IST
New Delhi [India], November 11 (ANI): People will need booster doses of the COVID-19 vaccine if the COVID-19 virus gets mutated, said Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella.
Read More
Hong Kong approves Bharat Biotech's Covaxin
Updated : 4 years, 4 months ago IST
Hong Kong, November 10 (ANI): Hong Kong has recognised Hyderabad-based pharmaceutical firm Bharat Biotech's Covaxin on its approved COVID-19 vaccine list.
Read More
Covaxin for Children will take some more time for final approval: Sources
Updated : 4 years, 4 months ago IST
New Delhi [India], November 8 (ANI): The data for Bharat Biotech's Covaxin for Children, COVID-19 vaccine, is under evaluation and the process will take some more time for final approval from the Drugs Controller General of India (DCGI), sources said.
Read More